CClinicalTrials.gg
CompletedNCT04542343Updated May 22, 2024Results posted

COVID-19 Risk Reduction Among African American Parishioners

An interventional study of Change in knowledge, motivation, skills, resources in Coronavirus, sponsored by Charles Drew University of Medicine and Science. Completed at 1 site in United States. Open to participants aged 55 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-22.

Sponsored by Charles Drew University of Medicine and Science · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
405
Allocation
Not applicable
Ages
55 Years and older
Sex
All
01

Study summary

African American adults, specifically those managing chronic disease and social isolation, are one of the most vulnerable groups susceptible to COVID-19. This intervention involves a multi-disciplinary and culturally sensitive approach to address two major COVID-19 related challenges in this population. First, this program collaborates with predominantly African American churches to implement Federal and State guidelines aimed at preventing outbreaks of COVID-19 at faith-based gatherings. Second, this program trains church-based health advisors to help African American older parishioners manage their chronic health conditions and reduce psychological distress during the pandemic.

Read the detailed description

To jointly implement and evaluate a telehealth-based, multidisciplinary, culturally-sensitive intervention with 265 AA older parishioners: (i) To mitigate the negative impact of COVID-19 on the management of chronic health conditions, and (ii) to reduce healthcare avoidance behaviors and psychological distress.

02

Conditions studied

  • Coronavirus
03

In context

Coronavirus Infections

929 studies on the registry are indexed under Coronavirus Infections; 50 are open to participants now.

This study's enrollment of 405 is above the median of 107 across 541 interventional studies indexed under Coronavirus Infections.

Browse Coronavirus Infections studies →

Lead sponsor

Charles Drew University of Medicine and Science is the lead sponsor of 41 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • African American older adults aged 55 years with a chronic medical condition or 65years and older
  • Have at least one risk factor for COVID-19

Exclusion criteria

Exclusion Criteria:

  • Resident of care facility
  • Cognitive deficit (identified by short version of mini-mental instrument)
  • Does not self-identify as African American and/or Black
  • Under the age of 55years
  • Unable to speak and/or read English
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
405 participants (actual)

Study arms

  • Experimental
    Risk Reduction of COVID-19 Among African American Parishioners

    This arm will implement "one group pretest-posttest" design to improve COVID associated health outcomes of AA older parishioners in collaboration with trained young church-based health educators.

    Behavioral: Change in knowledge, motivation, skills, resources

Interventions

  • BehavioralChange in knowledge, motivation, skills, resources

    Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 related risk and challenges.

06

What researchers measure

Primary outcomes

  1. Mean Change in the Ability to Implement COVID-19 Health Guidelines Among African American Churches in South Los Angeles 3 Months After Workshop

    This measure evaluates the readiness of African American church leaders in South Los Angeles to reopen their churches according to Federal and State COVID-19 guidelines. It specifically assesses their confidence and ability to implement safety protocols learned during the workshops, using the "Church Reopening Preparedness" construct of the Church Leaders' Pandemic Outreach \& Preparedness Scale (CLOPS) \[Cronbach's alpha of 0.97\]. This construct measures effectiveness on a Likert scale from 1 (strongly disagree) to 5 (strongly agree), reflecting how well leaders apply these protocols to ensure a safe worship environment. Higher Scores indicate effective readiness to implement safety measures. Lower Scores suggest areas where further training or planning is needed. Positive numbers indicate increases in preparedness to reopen faith-based organizations.

    Time frame: 3 months. The assessments were conducted immediately before the workshop (baseline) and repeated three months after to measure changes in preparedness.

  2. Mean Change in COVID-19 Knowledge Among Faith-based Leaders After Educational Workshop

    Church Leaders' Pandemic Outreach \& Preparedness Scale (CLOPS) is designed to assess the effectiveness of COVID-19 workshops in changing the preparedness of church leaders to reopen churches and to deepen their knowledge about COVID-19 (Cronbach's alpha of 0.97) . Positive mean differences indicate increases in preparedness to reopen these faith-based organizations. The general COVID-19 knowledge enhancement construct measures the increase in participants' understanding of COVID-19, including its transmission and preventive measures on a Likert scale from 1 (strongly disagree) to 5 (strongly agree). Higher scores indicate an enhanced knowledge of COVID-19 (better outcome). Lower scores suggest gaps in workshop content or participant comprehension (worse outcome).

    Time frame: 3 days from the start of the workshops (baseline) to completion of workshop training sessions.

  3. Number of Faith-based COVID-19 Health Ambassadors Who Attended at Least 2 Out of the 3-Day Training Workshops

    The outcome measure was primarily determined by the count of health ambassadors' attendance in a minimum of two out of three training sessions (each session held daily). These 3-day sessions encompassed interactive discussions and informal knowledge assessments designed to ensure comprehension and retention of critical COVID-19 information. The informal assessments were diverse, including group discussions where participants articulated preventive measures against COVID-19, role-playing to exemplify how they would convey complex health information to various community demographics, particularly older adults with underlying health conditions, and impromptu Q\&A segments aimed at evaluating participants' understanding of essential topics and rectifying any misconceptions immediately.

    Time frame: 3 days from the start of the workshops (baseline) to completion of workshop training sessions.

  4. Mean Change in Preparedness for COVID-19 Testing, Vaccination, and Health Promotion by Health Ambassadors After Training Workshop

    This outcome measure assesses the effectiveness of COVID-19 workshops in changing ambassadors' preparedness across five key constructs, as defined in CLOPS, including discussing infection risks, changing attitudes towards testing, boosting motivation for vaccination, convincing vaccine-hesitant individuals, and supporting older parishioners in managing chronic conditions amid the pandemic. Each construct is evaluated using a Likert scale from 1 to 5, where higher scores reflect a high level of readiness and effectiveness in demonstrating strong persuasive abilities, communication skills, and a capacity to support healthcare needs. Conversely, lower scores pinpoint areas requiring enhanced training, additional resources, or improved strategies. The total score is the sum of all sub-scale scores and ranges from 5 to 25. A negative mean difference between combined construct scores indicates an increase in the post-workshop scores compared to the pre-workshop scores.

    Time frame: 3 days from the start of the workshops (baseline) to completion of workshop training sessions.

  5. Total Number of Older Adult Parishioners Who Filled/Refilled at Least One of Their Prescription(s) After 6 Months Intervention With Support From a Health Ambassador

    This measure assesses the total number of participants who successfully filled/refilled at least one medication at the end of the intervention. Older adult participants, with the help of health ambassadors, self-reported whenever they picked up a medication fill/refill from their pharmacy. Only participants with outstanding prescriptions were required to report. By this, the outcome seeks to evaluate the effectiveness of the intervention in enhancing medication management among older adults, particularly in navigating health-related challenges during the COVID-19 pandemic.

    Time frame: 6 months. The end of the intervention was marked by 6 months after the first scheduled meeting (baseline) between the health ambassador and older adult parishioners.

  6. Total Number of Older Adult Parishioners Who Received at Least One COVID-19 Vaccine After 6 Months Intervention With Support From a Health Ambassador

    Assessing the number of participants who had received at least one additional COVID-19 vaccine by the end of the intervention period with the aid of a health ambassador

    Time frame: 6 months. The end of the intervention was marked by 6 months after the first scheduled meeting (baseline) between the health ambassador and church members.

  7. Mean Change in Healthcare Utilization Among Older Adult Parishioners After 6 Months Intervention With Support From a Health Ambassador

    This measure examines the delay in healthcare utilization among study participants with an emphasis on understanding the effects of interventions aimed at reducing barriers to accessing primary care, specialty services, dental care, and medication fills. To quantify these delays, a scale called the Healthcare Utilization Delay Scale was created, incorporating four distinct constructs: delay in getting prescriptions filled or refilled, visiting primary care providers, receiving dental care, and visiting specialty services. Scores on the scale are from 0 (no delay in any service) to 4 (delay in all measured services). Higher scores indicate more delays in healthcare utilization, representing a worse outcome, whereas lower scores suggest fewer delays, indicating better access to healthcare services. A negative mean difference indicates reduction in healthcare utilization delay among parishioners (calculated as post- minus pre-intervention scores).

    Time frame: 6 months. The end of the intervention was marked by 6 months after the first scheduled meeting (baseline) between the health ambassador and church members.

  8. Mean Change in COVID-19 Knowledge Among Parishioners After 6 Months Intervention With Support From a Health Ambassador

    This outcome measure assesses the effectiveness of an intervention by health ambassadors designed to increase COVID-19 knowledge among older adult parishioners using a newly developed 19-item scale - COVID-19 Knowledge Scale (Cronbach alpha = 0.87).Each item on the scale assesses participants' understanding of key aspects of COVID-19, such as transmission methods, symptoms, prevention strategies, and treatment options, with responses recorded as binary (1 = correct or 0 = incorrect). The total knowledge score for each participant is derived by averaging the scores across all items, with potential scores ranging from 0 to 1 (actual average scores ranged from 0.10 to 1.0). Higher average scores on this scale indicate a better understanding of COVID-19, and improvements are reflected by a positive mean difference in scores before and after the intervention (calculated as post- minus pre-intervention scores).

    Time frame: 6 months. The end of the intervention was marked by 6 months after the first scheduled meeting (baseline) between the health ambassador and church members.

07

Results

Posted May 22, 2024

Participant flow

Participant flow — Overall Study
MilestoneAim 1: Faith-based LeadershipAim 2: COVID-19 Health AmbassadorsAim 3: Older African American Adults
Started1746152
Completed1019110
Not completed72742

Outcome measures

PrimaryMean Change in the Ability to Implement COVID-19 Health Guidelines Among African American Churches in South Los Angeles 3 Months After Workshop

This measure evaluates the readiness of African American church leaders in South Los Angeles to reopen their churches according to Federal and State COVID-19 guidelines. It specifically assesses their confidence and ability to implement safety protocols learned during the workshops, using the "Church Reopening Preparedness" construct of the Church Leaders' Pandemic Outreach \& Preparedness Scale (CLOPS) \[Cronbach's alpha of 0.97\]. This construct measures effectiveness on a Likert scale from 1 (strongly disagree) to 5 (strongly agree), reflecting how well leaders apply these protocols to ensure a safe worship environment. Higher Scores indicate effective readiness to implement safety measures. Lower Scores suggest areas where further training or planning is needed. Positive numbers indicate increases in preparedness to reopen faith-based organizations.

Time frame:
3 months. The assessments were conducted immediately before the workshop (baseline) and repeated three months after to measure changes in preparedness.
Reported as:
Mean · score on a scale of 1-5
Mean Change in the Ability to Implement COVID-19 Health Guidelines Among African American Churches in South Los Angeles 3 Months After Workshop
score on a scale of 1-5Aim 1: Faith-based Leadership
Mean Change in the Ability to Implement COVID-19 Health Guidelines Among African American Churches in South Los Angeles 3 Months After Workshop3.00000 (2.24600 to 3.75400)
Statistical analysis
  • Aim 1: Faith-based Leadership · t-test, 2 sided · p = <0.01 · Mean difference (net): 3.00000 · 95% CI 2.24600 to 3.75400
PrimaryMean Change in COVID-19 Knowledge Among Faith-based Leaders After Educational Workshop

Church Leaders' Pandemic Outreach \& Preparedness Scale (CLOPS) is designed to assess the effectiveness of COVID-19 workshops in changing the preparedness of church leaders to reopen churches and to deepen their knowledge about COVID-19 (Cronbach's alpha of 0.97) . Positive mean differences indicate increases in preparedness to reopen these faith-based organizations. The general COVID-19 knowledge enhancement construct measures the increase in participants' understanding of COVID-19, including its transmission and preventive measures on a Likert scale from 1 (strongly disagree) to 5 (strongly agree). Higher scores indicate an enhanced knowledge of COVID-19 (better outcome). Lower scores suggest gaps in workshop content or participant comprehension (worse outcome).

Time frame:
3 days from the start of the workshops (baseline) to completion of workshop training sessions.
Reported as:
Mean · score on a scale of 1-5
Mean Change in COVID-19 Knowledge Among Faith-based Leaders After Educational Workshop
score on a scale of 1-5Aim 1: Faith-Based Leadership
Mean Change in COVID-19 Knowledge Among Faith-based Leaders After Educational Workshop-3.30000 (-4.256785 to -2.343215)
Statistical analysis
  • Aim 1: Faith-Based Leadership · t-test, 2 sided · p = <0.001 · Mean difference (net): -3.30000 · 95% CI -4.256785 to -2.343215
PrimaryNumber of Faith-based COVID-19 Health Ambassadors Who Attended at Least 2 Out of the 3-Day Training Workshops

The outcome measure was primarily determined by the count of health ambassadors' attendance in a minimum of two out of three training sessions (each session held daily). These 3-day sessions encompassed interactive discussions and informal knowledge assessments designed to ensure comprehension and retention of critical COVID-19 information. The informal assessments were diverse, including group discussions where participants articulated preventive measures against COVID-19, role-playing to exemplify how they would convey complex health information to various community demographics, particularly older adults with underlying health conditions, and impromptu Q\&A segments aimed at evaluating participants' understanding of essential topics and rectifying any misconceptions immediately.

Time frame:
3 days from the start of the workshops (baseline) to completion of workshop training sessions.
Reported as:
Count of participants · Participants
Number of Faith-based COVID-19 Health Ambassadors Who Attended at Least 2 Out of the 3-Day Training Workshops
ParticipantsAim 2: COVID-19 Health Ambassadors
Number of Faith-based COVID-19 Health Ambassadors Who Attended at Least 2 Out of the 3-Day Training Workshops19
PrimaryMean Change in Preparedness for COVID-19 Testing, Vaccination, and Health Promotion by Health Ambassadors After Training Workshop

This outcome measure assesses the effectiveness of COVID-19 workshops in changing ambassadors' preparedness across five key constructs, as defined in CLOPS, including discussing infection risks, changing attitudes towards testing, boosting motivation for vaccination, convincing vaccine-hesitant individuals, and supporting older parishioners in managing chronic conditions amid the pandemic. Each construct is evaluated using a Likert scale from 1 to 5, where higher scores reflect a high level of readiness and effectiveness in demonstrating strong persuasive abilities, communication skills, and a capacity to support healthcare needs. Conversely, lower scores pinpoint areas requiring enhanced training, additional resources, or improved strategies. The total score is the sum of all sub-scale scores and ranges from 5 to 25. A negative mean difference between combined construct scores indicates an increase in the post-workshop scores compared to the pre-workshop scores.

Time frame:
3 days from the start of the workshops (baseline) to completion of workshop training sessions.
Reported as:
Mean · score on a scale
Mean Change in Preparedness for COVID-19 Testing, Vaccination, and Health Promotion by Health Ambassadors After Training Workshop
score on a scaleAim 2: COVID-19 Health Ambassadors
Mean Change in Preparedness for COVID-19 Testing, Vaccination, and Health Promotion by Health Ambassadors After Training Workshop-16.4 (-19.96 to -12.64)
PrimaryTotal Number of Older Adult Parishioners Who Filled/Refilled at Least One of Their Prescription(s) After 6 Months Intervention With Support From a Health Ambassador

This measure assesses the total number of participants who successfully filled/refilled at least one medication at the end of the intervention. Older adult participants, with the help of health ambassadors, self-reported whenever they picked up a medication fill/refill from their pharmacy. Only participants with outstanding prescriptions were required to report. By this, the outcome seeks to evaluate the effectiveness of the intervention in enhancing medication management among older adults, particularly in navigating health-related challenges during the COVID-19 pandemic.

Time frame:
6 months. The end of the intervention was marked by 6 months after the first scheduled meeting (baseline) between the health ambassador and older adult parishioners.
Reported as:
Count of participants · Participants
Total Number of Older Adult Parishioners Who Filled/Refilled at Least One of Their Prescription(s) After 6 Months Intervention With Support From a Health Ambassador
ParticipantsAim 3: Older African American Adults
Total Number of Older Adult Parishioners Who Filled/Refilled at Least One of Their Prescription(s) After 6 Months Intervention With Support From a Health Ambassador80
PrimaryTotal Number of Older Adult Parishioners Who Received at Least One COVID-19 Vaccine After 6 Months Intervention With Support From a Health Ambassador

Assessing the number of participants who had received at least one additional COVID-19 vaccine by the end of the intervention period with the aid of a health ambassador

Time frame:
6 months. The end of the intervention was marked by 6 months after the first scheduled meeting (baseline) between the health ambassador and church members.
Reported as:
Count of participants · Participants
Total Number of Older Adult Parishioners Who Received at Least One COVID-19 Vaccine After 6 Months Intervention With Support From a Health Ambassador
ParticipantsAim 3: Older African American Adults
Total Number of Older Adult Parishioners Who Received at Least One COVID-19 Vaccine After 6 Months Intervention With Support From a Health Ambassador107
PrimaryMean Change in Healthcare Utilization Among Older Adult Parishioners After 6 Months Intervention With Support From a Health Ambassador

This measure examines the delay in healthcare utilization among study participants with an emphasis on understanding the effects of interventions aimed at reducing barriers to accessing primary care, specialty services, dental care, and medication fills. To quantify these delays, a scale called the Healthcare Utilization Delay Scale was created, incorporating four distinct constructs: delay in getting prescriptions filled or refilled, visiting primary care providers, receiving dental care, and visiting specialty services. Scores on the scale are from 0 (no delay in any service) to 4 (delay in all measured services). Higher scores indicate more delays in healthcare utilization, representing a worse outcome, whereas lower scores suggest fewer delays, indicating better access to healthcare services. A negative mean difference indicates reduction in healthcare utilization delay among parishioners (calculated as post- minus pre-intervention scores).

Time frame:
6 months. The end of the intervention was marked by 6 months after the first scheduled meeting (baseline) between the health ambassador and church members.
Reported as:
Mean · score on a scale
Mean Change in Healthcare Utilization Among Older Adult Parishioners After 6 Months Intervention With Support From a Health Ambassador
score on a scaleAim 3: Older African American Adults
Mean Change in Healthcare Utilization Among Older Adult Parishioners After 6 Months Intervention With Support From a Health Ambassador-0.21818 (-0.36828 to -0.06809)
Statistical analysis
  • Aim 3: Older African American Adults · t-test, 2 sided · p = <0.01 · Mean difference (net): -0.21818 · 95% CI -0.36828 to -0.06809
PrimaryMean Change in COVID-19 Knowledge Among Parishioners After 6 Months Intervention With Support From a Health Ambassador

This outcome measure assesses the effectiveness of an intervention by health ambassadors designed to increase COVID-19 knowledge among older adult parishioners using a newly developed 19-item scale - COVID-19 Knowledge Scale (Cronbach alpha = 0.87).Each item on the scale assesses participants' understanding of key aspects of COVID-19, such as transmission methods, symptoms, prevention strategies, and treatment options, with responses recorded as binary (1 = correct or 0 = incorrect). The total knowledge score for each participant is derived by averaging the scores across all items, with potential scores ranging from 0 to 1 (actual average scores ranged from 0.10 to 1.0). Higher average scores on this scale indicate a better understanding of COVID-19, and improvements are reflected by a positive mean difference in scores before and after the intervention (calculated as post- minus pre-intervention scores).

Time frame:
6 months. The end of the intervention was marked by 6 months after the first scheduled meeting (baseline) between the health ambassador and church members.
Reported as:
Mean · score on a scale
Mean Change in COVID-19 Knowledge Among Parishioners After 6 Months Intervention With Support From a Health Ambassador
score on a scaleAim 3: Older African American Adults
Mean Change in COVID-19 Knowledge Among Parishioners After 6 Months Intervention With Support From a Health Ambassador0.05623 (0.00459 to 0.10788)
Statistical analysis
  • Aim 3: Older African American Adults · t-test, 2 sided · p = <0.05 · Mean difference (net): 0.05623 · 95% CI 0.00459 to 0.10788

Adverse events

Collected over 6 months. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Aim 1: Faith-based Leadership0/17 (0%)0/17 (0%)0/17 (0%)
Aim 2: COVID-19 Health Ambassadors0/46 (0%)0/46 (0%)0/46 (0%)
Aim 3: Older African American Adults0/152 (0%)0/152 (0%)0/152 (0%)

Baseline characteristics

AIM1: Faith-based Leadership The arm consists of recruited faith-based leaders who play a pivotal role in community guidance and influence. Aim 2: COVID-19 Health Ambassadors Participants were recruited from various faith-based organizations showing interest in health advocacy. AIM 3: Older African American Adults The participants in this group are older adultswho are particularly vulnerable to COVID-19 and often face multiple challenges in managing chronic health conditions.

Age, Categorical
Age, Categorical(Participants)Aim 1: Faith-based LeadershipAim 2: COVID-19 Health AmbassadorsAim 3: Older African American AdultsTotal
<=18 years0000
Between 18 and 65 years4102943
>=65 years698196
Sex: Female, Male
Sex: Female, Male(Participants)Aim 1: Faith-based LeadershipAim 2: COVID-19 Health AmbassadorsAim 3: Older African American AdultsTotal
Female2157794
Male843345
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Aim 1: Faith-based LeadershipAim 2: COVID-19 Health AmbassadorsAim 3: Older African American AdultsTotal
American Indian or Alaska Native0000
Asian0000
Native Hawaiian or Other Pacific Islander0000
Black or African American1019110139
White0000
More than one race0000
Unknown or Not Reported0000
08

Study locations

1 site
  • Charles R. Drew University of Medicine & Science
    Los Angeles, California 90059, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Apr 23, 2021
  • Informed consent form · Apr 23, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04542343
Lead sponsor
Charles Drew University of Medicine and Science
Collaborators
National Institute on Minority Health and Health Disparities (NIMHD)
Responsible party
Sponsor
First posted
Sep 9, 2020
Start date
Jun 1, 2021
Primary completion
Dec 30, 2022
Completion
Dec 30, 2022
Results posted
May 22, 2024
Last update
May 22, 2024

Study contacts

Mohsen Bazargan, PhD
principal investigator · Charles R. Drew University of Medicine & Science

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion